3SBio Inc. (沈阳三生制药) announced that 2008 revenues rose 35% to 243 million RMB ($35.7 million). At the same time, following a trend seen in much of China biopharma, net income failed to keep pace with the increase in revenue. 3SBio said non-GAAP net income was 75 million RMB ($11 million) for the year, almost even with 2007’s results. More details...

Stock Symbol: (NSDQ: SSRX)